These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 6255009)

  • 41. Effect of heparin on the vascular distribution of *I-antithrombin III isoforms in rabbits.
    Carlson TH
    Thromb Res; 1989 Aug; 55(4):471-80. PubMed ID: 2814938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of glycosaminoglycans and antithrombin III on uptake and inhibition of thrombin by the vascular wall.
    Dryjski M; Larsson R; Olsson P; Swedenborg J
    Thromb Res; 1983 Nov; 32(4):355-63. PubMed ID: 6658719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin.
    de Boer HC; Preissner KT; Bouma BN; de Groot PG
    J Biol Chem; 1992 Feb; 267(4):2264-8. PubMed ID: 1370815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of heparin chain length in the heparin-catalyzed inhibition of thrombin by antithrombin III.
    Hoylaerts M; Owen WG; Collen D
    J Biol Chem; 1984 May; 259(9):5670-7. PubMed ID: 6715365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo catabolism of heparin cofactor II and its complex with thrombin: evidence for a common receptor-mediated clearance pathway for three serine proteinase inhibitors.
    Pratt CW; Church FC; Pizzo SV
    Arch Biochem Biophys; 1988 Apr; 262(1):111-7. PubMed ID: 3258496
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
    Stone SR; Le Bonniec BF
    J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heparin fractions with high and low affinities to antithrombin III are cleared at different rates.
    Caranobe C; Petitou M; Dupouy D; Gabaig AM; Sié P; Buchanan MR; Boneu B
    Thromb Res; 1986 Sep; 43(6):635-41. PubMed ID: 3764809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The chondroitin sulfate moiety of thrombomodulin binds a second molecule of thrombin.
    Ye J; Esmon CT; Johnson AE
    J Biol Chem; 1993 Feb; 268(4):2373-9. PubMed ID: 8381406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A simple rate law that describes the kinetics of the heparin-catalyzed reaction between antithrombin III and thrombin.
    Nesheim ME
    J Biol Chem; 1983 Dec; 258(23):14708-17. PubMed ID: 6643505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formation and stability of the complex formed between human antithrombin-III and thrombin.
    Ferguson WS; Finlay TH
    Arch Biochem Biophys; 1983 Jan; 220(1):301-8. PubMed ID: 6338832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification in vitro of an endothelial cell surface cofactor for antithrombin III. Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium.
    Busch C; Owen WG
    J Clin Invest; 1982 Mar; 69(3):726-9. PubMed ID: 7061710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of the binding of bovine thrombin to isolated rat hepatocytes.
    Weyer B; Petersen TE; Sonne O
    Thromb Haemost; 1988 Dec; 60(3):419-27. PubMed ID: 2853460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of thrombin-antithrombin III complex with vitronectin in serum.
    Ill CR; Ruoslahti E
    J Biol Chem; 1985 Dec; 260(29):15610-5. PubMed ID: 2415521
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heparin and ionic strength-dependent conversion of antithrombin III from an inhibitor to a substrate of alpha-thrombin.
    Olson ST
    J Biol Chem; 1985 Aug; 260(18):10153-60. PubMed ID: 4019506
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA; Pastorova VE; Liapina LA
    Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Purification and characterization of rat plasma antithrombin III.
    Takahara H; Sinohara H
    Biochim Biophys Acta; 1980 Mar; 612(1):185-94. PubMed ID: 7362830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of prothrombin fragment 2 on the inhibition of thrombin by antithrombin III.
    Walker FJ; Esmon CT
    J Biol Chem; 1979 Jul; 254(13):5618-22. PubMed ID: 447671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The heparin-enhanced antithrombin III/thrombin reaction is saturable with respect to both thrombin and antithrombin III.
    Griffith MJ
    J Biol Chem; 1982 Dec; 257(23):13899-302. PubMed ID: 7142182
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Linkage of protease-inhibitor-heparin interactions in the reaction with thrombin.
    Olson ST
    J Biol Chem; 1988 Feb; 263(4):1698-708. PubMed ID: 3338989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Probing plasma clearance of the thrombin-antithrombin complex with a monoclonal antibody against the putative serpin-enzyme complex receptor-binding site.
    Long GL; Kjellberg M; Villoutreix BO; Stenflo J
    Eur J Biochem; 2003 Oct; 270(20):4059-69. PubMed ID: 14519117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.